等待開盤 01-13 09:30:00 美东时间
-0.780
-1.43%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从47美元升至48美元;BTIG:维持Hudson Pacific Properties"买入"评级,目标价从4.75美元升至26美元
01-05 13:52
Keefe, Bruyette & Woods analyst Sanjay Sakhrani maintains BILL Holdings (NYSE:BILL) with a Market Perform and raises the price target from $52 to $60.
01-03 01:39
Some investment firms make their reputation by telling great stories. Elliott I...
2025-12-26 23:41
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
BTIG analyst Andrew Harte maintained a Buy rating on Bill.com Holdings today an...
2025-12-12 18:56
BTIG analyst Andrew Harte reiterates BILL Holdings (NYSE:BILL) with a Buy and maintains $60 price target.
2025-12-12 18:53
BILL Holdings shares are trading higher after shareholder Barington Capital rec...
2025-12-04 22:09
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28
Truist Securities analyst Matthew Coad maintains BILL Holdings (NYSE:BILL) with a Buy and lowers the price target from $61 to $60.
2025-11-20 01:55